Earnings Preview — 2814 total
A2Z Cust2Mate Solutions Corp. reports Q1 2026 results today with its short interest near a one-month high and options traders the most defensive they have been in weeks. The options market has turned sharply cautious…
CISO Global Inc. reports Q1 2026 results today against an unusual backdrop: a micro-cap cybersecurity firm with a market cap of roughly $13 million, a stock up 10% on the day and 13.5% on the week, yet down 12% over…
NeoVolta Inc. heads into its Q3 2026 earnings print with a lending market that remains meaningfully tight and a short position that, while easing this week, still holds over 10% of the free float. The clearest signal…
MTVA heads into its May 18 earnings print carrying one of the most expensive borrow costs in the biotech universe — a signal that short-side pressure, while not dominant by position size, is punishingly costly to…
KULR Technology Group reports today with one of the most constrained borrow markets in its peer universe — and a stock that just rallied 40% in a week, creating a tense setup for the print. Short sellers have built an…
Bit Digital reports Q1 2026 results today with options traders at their most bullish in a year — a sharp contrast to the elevated short position still sitting in the stock. The options signal is striking. The put/call…
PRPO dropped its Q1 2026 results after the close on May 14, delivering a revenue beat alongside a deeper-than-year-ago loss — the kind of split verdict that leaves investors doing the math on growth versus…
Voyager Therapeutics reports today with one striking contradiction: the stock is up 10% over the past month, yet executives have been consistently selling into that strength. The insider signal is the standout here.…
BT Brands heads into its May 15 earnings report having already delivered the headline: Q1 2026 results dropped after the close on May 14, showing EPS of -$0.12 against -$0.05 a year ago, and revenue of $2.84M against…
Arcadia Biosciences heads into its May 15 earnings report as one of the more technically distressed micro-caps on Nasdaq, with the stock down nearly 50% year-to-date and trading at $1.07. The price tells the clearest…
XBiotech Inc. heads into today's earnings print with options positioning at its most defensive level in months — a sharp divergence from an otherwise quiet short-selling picture. The clearest signal is in options. The…
enCore Energy heads into today's Q1 2026 earnings event already having delivered the print — and the numbers are better than the Street expected. Q1 EPS came in at $0.03 against a consensus estimate of -$0.08. Revenue…
PEDEVCO Corp. reports today with short sellers pulling back and borrowing costs easing — a setup that looks more relaxed than charged. The clearest signal heading into the print is what bears are not doing. Short…
Propanc Biopharma heads into its May 18 earnings release as one of the more volatile micro-cap biotechs on the Nasdaq calendar, with short interest surging and its stock price hitting new lows. The short interest story…
Fortress Biotech heads into its Q1 2026 print with one of the most elevated short positioning profiles among small-cap biotechs. Short sellers are heavily committed. At 14.6% of free float, short interest is material…
VolitionRx walks into today's Q1 2026 print with a dramatically altered short-seller landscape — one where a massive cover-down has reshaped the positioning story entirely. The most striking shift is in short interest.…
Lixte Biotechnology Holdings heads into its May 15 earnings report on the back of a 72% price surge over the past month — and with insiders who evidently share the enthusiasm. The most striking element of the…
Short sellers hold no meaningful grip on SCOR ahead of tonight's Q1 2026 results — and the lending market confirms it. Short interest is negligible at just 0.52% of the free float, with borrow availability running at…
Bio Green Med Solution, Inc. reports on May 18 with short sellers holding a relatively modest position — but the borrow market tells a more complicated story. Short interest is less than 1% of the free float at roughly…
CSAN3 reports Q1 2026 results today against one of its toughest price backdrops in recent memory. The stock has shed 16% over the past month and nearly 11% in the past week alone, arriving at BRL 4.65 — well below the…
